Since its approval for high-surgical-risk (HSR) patients in 2004, transfemoral carotid artery stenting (TFCAS) utilization has slowly increased.1 However, conflicting trial data and retrospective analyses suggested that TFCAS was associated with a prolonged learning curve and relatively high stroke risk.2-6 It was surpassed by transcarotid artery revascularization (TCAR) in centers participating in the Society for Vascular Surgery’s Vascular Quality Initiative Transcarotid Surveillance...
